Milan, Italy, October 2026 – Adalvo is proud to announce that its Founder and CEO, Anil Okay, has been named CEO of the Year at the prestigious CPHI Awards 2026, recognising his exceptional leadership, strategic vision, and contributions to advancing the global pharmaceutical industry.
The award celebrates leaders who have demonstrated outstanding business performance, innovation, and industry impact. Since founding Adalvo in 2018, Anil has transformed the company into one of the pharmaceutical industry's fastest-growing and most differentiated B2B organisations, building a global platform focused on innovation, execution excellence, and long-term partnerships.
Under his leadership, Adalvo has expanded its international footprint, developed one of the industry's largest differentiated product portfolios, and established itself as a trusted partner for pharmaceutical companies worldwide. Anil's ability to combine bold strategic thinking with a people-first leadership approach has been instrumental in driving the company's continued growth and success.
"This award is a reflection of the incredible people who make Adalvo what it is today. Our success has always been built on the talent, commitment, and ambition of our team, as well as the trust of our partners and customers around the world. I am honoured to accept this recognition on behalf of everyone who contributes to our shared journey."
This recognition marks another important milestone for Adalvo and reinforces the company's commitment to shaping the future of healthcare through innovation, collaboration, and execution excellence.